Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00761618 · ClinicalTrials.gov registry record · Phase 2
Intrapleural Catheter Daily Versus Three Times a Week Drainage
A Phase 2 study of Advanced Cancer and Pleural Effusion, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 257
- Enrollment target
- 1
- Study location
NCT00761618: Active Phase 2 study of Advanced Cancer and Pleural Effusion, sponsored by M.D. Anderson Cancer Center.
NCT00761618 is a Phase 2 study of Advanced Cancer and Pleural Effusion that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 257 participants, roughly in line with the 244-participant average among 122 other Advanced Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00761618, a Phase 2 study of Advanced Cancer and Pleural Effusion, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 257 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn if draining the IPC every day is better at than draining it 3 times a week.
Primary Outcome
Time to pleurodesis (TTP), defined as the time from catheter insertion to catheter removal.
Conditions Studied
Interventions
- PROCEDURE Intrapleural catheter (IPC) drained
- PROCEDURE IPC Placement
- RADIATION Chest X-Ray
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2008-08-22 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 2 |
What the registry record for NCT00761618 still lists
NCT00761618 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 244-participant average among 122 other Advanced Cancer trials with a reported enrollment target.
The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 3 interventions - of which Intrapleural catheter (IPC) drained is the first listed.
NCT00761618 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00761618 about?
NCT00761618 is a clinical study titled "Intrapleural Catheter Daily Versus Three Times a Week Drainage". The goal of this clinical research study is to learn if draining the IPC every day is better at than draining it 3 times a week.
What is the current status of trial NCT00761618?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 257 participants. The study started on 2008-08-22. Estimated completion is 2026-08-31.
What conditions does trial NCT00761618 study?
This clinical trial studies the following conditions: Advanced Cancer, Pleural Effusion.
What interventions are being tested in trial NCT00761618?
The interventions under investigation include: Intrapleural catheter (IPC) drained (PROCEDURE), IPC Placement (PROCEDURE), Chest X-Ray (RADIATION).
Who is sponsoring clinical trial NCT00761618?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00761618 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00761618's enrollment target sits among peer trials
257 24th of 122 higher than 99 of 122 other Advanced Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
RECRUITING · Phase 2
-
Psilocybin in Cancer Pain Study
RECRUITING · Phase 2
-
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RECRUITING · Phase 2
-
Psilocybin Therapy in Advanced Cancer
RECRUITING · Phase 2
-
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI